Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001041554 | SCV001205178 | likely benign | Nemaline myopathy 6 | 2024-10-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002551498 | SCV003541122 | uncertain significance | Inborn genetic diseases | 2022-03-29 | criteria provided, single submitter | clinical testing | The c.1038G>T (p.M346I) alteration is located in exon 1 (coding exon 1) of the KBTBD13 gene. This alteration results from a G to T substitution at nucleotide position 1038, causing the methionine (M) at amino acid position 346 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |